New Key Statistics Module, Z-Score and F-Score
NAS:XFOR Key Ratios
Market Cap $ M | 106.10 |
Enterprise Value $ M | 12.16 |
P/E(ttm) | 7.00 |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 1.12 |
Price/Sales | 197.39 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | 6.45 |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | 0.09 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 54.70 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 0.48 |
EV-to-EBITDA | 0.47 |
PEG | -- |
Shares Outstanding M | 168.50 |
Net Margin (%) | 3,131.79 |
Operating Margin % | -21,953.64 |
Pre-tax Margin (%) | 3,148.85 |
Quick Ratio | 6.04 |
Current Ratio | 6.07 |
ROA % (ttm) | 10.79 |
ROE % (ttm) | 31.29 |
ROIC % (ttm) | -346.55 |
Dividend Yield % | -- |
Altman Z-Score | -1.15 |
XFOR Number of Guru Trades
XFOR Volume of Guru Trades
Gurus Latest Trades with NAS:XFOR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:XFOR is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
X4 Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:XFOR
Total 0- 1